Skip to content
FloodGate Medical
Linda Ray

Linda Ray

Genomics & Precision Medicine Practice Lead

Based in
Austin, Texas (remote)
At FloodGate since
2026
Years in Genomics
25

I started in genomics sequencing chromosome 22 for the Human Genome Project. A conversation at the very first Advances in Genome Biology and Technology meeting (AGBT) moved me to the commercial side. I spent the next 25 years there at SeqWright, Agencourt, Beckman Coulter, and Illumina.

Now I help genomics companies assemble high-performing teams that will change medicine. I've sat in and with the roles my clients are hiring for. I know many of the people who can fill them. And I know what it feels like to work with the most talented people in the field toward making an impact.

Working with people from different companies and backgrounds feels like matchmaking in the best way. I'm passionate about building amazing teams for my clients to advance science and medicine, and following genomics' continued trajectory from the bench to the clinic.

25+Years in genomics and life sciences commercial roles
105%Of a $46M quota as a strategic accounts manager
9Reps led as a regional manager, on $26M in quota
Experience

The path here

Fills most often

  • Territory and field sales
  • Clinical specialists and education
  • Sales leadership (RSM, director, VP)

Coverage. Also marketing and product management, operations and service, and executive roles; these three most often. Knows Texas and the South Central region best, including the Texas Medical Center, along with the Rocky Mountain West and national strategic accounts.

  1. Genomics & Precision Medicine Practice LeadNow

    Sep 2026 to present

    FloodGate Medical

    Building FloodGate's genomics and precision medicine practice.

  2. Consulting Commercial Director, Strategic Partnerships

    2025 to 2026

    Sequins

    Led partnerships and go-to-market for synthetic NGS controls.

  3. Associate Director, Commercial Lead, Genetic Disease Testing

    2025

    Illumina

    Led US partnerships for newborn sequencing, cardio genomics and national genomics initiatives.

  4. Associate Director, National Strategic Project Lead

    2024 to 2025

    Illumina

    Newborn sequencing market development with NIH, CDC and state public health labs.

  5. National Strategic Project Lead

    2022 to 2024

    Illumina

    Commercial lead for an acquired diagnostics company during its hold-separate period, working daily with legal teams and trustees. Led a cross-functional team that engaged Utah's Medicaid director, securing approval of rapid whole genome sequencing for critically ill NICU infants.

  6. Key Account Manager to Executive Strategic Accounts Manager

    2014 to 2022

    Illumina

    Carried $30M to $60M named accounts, including a major academic medical center. Hit 105% of a $46M quota.

  7. Regional Manager, Rocky Mountain West

    2014

    Beckman Coulter Life Sciences

    Managed nine reps and $26M in quota.

  8. Account Manager to Senior Sales Consultant

    2003 to 2014

    Agencourt Biosciences / Beckman Coulter

    Sample prep sales to genomics labs. Inner Circle Award, 2010.

  9. Sales and Marketing

    2000 to 2003

    SeqWright

    Sold genomic services worldwide, and supervised a team of three.

  10. Lab Project Coordinator

    1997 to 2000

    University of Oklahoma Advanced Center for Genomic Technology

    Human Genome Project sample tracking and sequencing.

A search worth describing

Before FloodGate: rapid genome sequencing for critically ill infants in Utah

Critically ill NICU babies in Utah were waiting too long for a diagnosis because Medicaid didn't cover rapid whole genome sequencing. The hard part wasn't the science. It was getting clinicians, payers and policy leaders behind one ask. I took what we'd learned from a similar effort in Texas and led a cross-functional team, including Market Access, that went straight to the state Medicaid director. In November 2023, Utah approved rapid whole genome sequencing as a first-line diagnostic for these infants. It showed me how powerful it is when academic, clinical and patient advocates align on making an impact for the next generation.

Expertise

Linda’s corner of genomics and precision medicine.

  • How to tell if a genomics rep's book of business is real
  • What great genomics commercial teams have in common: collaboration across every function that touches the customer, and a network that reaches well beyond their own company
  • Hiring commercial leaders for the move from research use only to clinical diagnostics
  • Landing your next commercial role after a biotech layoff
  • Selling NGS platforms, robotics and related services into academic medical centers, clinical accounts, biotechs, government and pharma
Credentials and training

Trained, and certified for it.

  • Degree

    B.S., Biological Sciences

    University of Oklahoma

  • Program

    Lead 4 Success

    Center for Creative Leadership

    2023

  • Certificate

    Health Care Economics

    Harvard Business School Online

    2022

  • Program

    Strategic Account Management

    2018

  • Program

    Leadership Development Program

    Beckman Coulter

    2012 to 2013

  • Sales training

    SPIN Selling, Miller Heiman, Challenger Sales, Crucial Conversations and Situational Leadership

A point of view

What most people get wrong

  • The belief

    A big quota history means the rep can sell genomics anywhere.

    The reality

    The number doesn't tell you if they're a hunter or a farmer. Both matter. A rep coming from the market leader may have built much of their number by growing an installed base. A startup launching a new platform needs someone who can win from scratch. I ask what they won versus what they grew.

  • The belief

    A great research sales rep will be great in clinical diagnostics.

    The reality

    It's a different job. Clinical is more regulated in what you can say and do, with fewer products and less variety in customers. The training is different too. Some reps thrive there. Some dislike it. Better to find out before the offer.

  • The belief

    You need a PhD to sell genomics.

    The reality

    Science matters, but it isn't the job. I worked with many brilliant PhDs, and not all of them made a successful move into sales.

  • The belief

    Top sellers win on their own.

    The reality

    In genomics, the best ones win through other people. Inside the company, that means R&D, medical affairs, market access, marketing, field application scientists and service. Outside, it's lab directors, key opinion leaders and a network that follows them from company to company. I ask candidates who they pulled in to close their biggest deal.

Away from work

Lives in Austin, Texas. A wife and mother who plays tennis and golf, gardens, cooks, travels and takes a lot of photos. A proud University of Oklahoma alum.

Last reviewed by Linda Ray on .

25+ years of pattern recognition in MedTech talent
The people who got you here may not be the people who can get you there.

Talk to Linda about what you're trying to accomplish.